Table 1 Baseline characteristics
From: Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome
Variable | Complete case | Men | Women | ||
|---|---|---|---|---|---|
Non-progressors | Progressors | Non-progressors | Progressors | ||
FPG (mmol/L) | 521 (99%) | 5.9 (0.8) | 7.1 (1.2) | 5.7 (0.6) | 6.7 (0.6) |
BMI (kg/m2) | 524 (100%) | 30.3 (3.8) | 35.6 (5.4) | 30.7 (4.6) | 34.6 (5.4) |
Waist circumference (cm) | 520 (99%) | 106.6 (9.4) | 116.5 (9.7) | 100.8 (9.6) | 108.9 (7.3) |
OGTT glucose (mmol/L) | 425 (81%) | 5.4 (1.6) | 6.9 (1.8) | 6.3 (1.7) | 7.8 (1.8) |
HbA1c (%) | 405 (77%) | 5.6 (0.2) | 6.0 (0.5) | 5.7 (0.3) | 5.9 (0.2) |
Quicki | 326 (62%) | 0.1 (0.0) | 0.1 (0.0) | 0.1 (0.0) | 0.1 (0.0) |
MetS score (0–5) | 525 (100%) | 3.3 (1.0) | 3.8 (0.8) | 3.4 (1.0) | 4.3 (0.7) |
Weight (kg) | 524 (100%) | 95.4 (13.9) | 107.6 (16.2) | 80.0 (12.9) | 87.6 (12.9) |
ISIMatsuda | 299 (57%) | 7.8 (5.4) | 3.8 (2.4) | 6.6 (4.8) | 3.3 (2.2) |
OGTT insuline (pmol/l) | 301 (57%) | 254.5 (199.3) | 473.7 (209.2) | 415.5 (345.8) | 694.7 (492.8) |
HOMA-IR | 326 (62%) | 3.2 (1.8) | 5.7 (2.3) | 3.4 (2.6) | 4.9 (2.0) |
Fasting insuline (pmol/l) | 326 (62%) | 84.3 (43.0) | 131.9 (49.3) | 88.0 (61.6) | 115.5 (49.0) |
HDL cholesterol (mmol//l) | 523 (100%) | 1.2 (0.3) | 1.1 (0.2) | 1.4 (0.3) | 1.2 (0.2) |
LDL cholesterol (mmol/L) | 524 (100%) | 4.3 (1.2) | 3.7 (1.1) | 4.8 (1.3) | 4.4 (0.9) |
Total cholesterol (mmol/l) | 525 (100%) | 6.7 (1.4) | 6.1 (1.3) | 7.1 (1.4) | 6.7 (1.2) |
hs-CRP (mg/L) | 502 (96%) | 4.0 (6.8) | 3.9 (4.3) | 2.9 (3.2) | 7.2 (13.7) |
ISICederholm | 299 (57%) | 75088.2 (1048.6) | 75363.3 (1453.0) | 74441.7 (1223.9) | 73737.3 (1848.3) |
Age (years) | 525 (100%) | 48.0 (4.0) | 49.1 (4.4) | 56.9 (4.1) | 56.9 (3.6) |
Smoking status | 522 (99%) | ||||
Never | 82 (49%) | 8 (50%) | 267 (83%) | 15 (94%) | |
Former | 13 (8%) | 0 (0%) | 7 (2%) | 0 (0%) | |
Current | 73 (43%) | 8 (50%) | 48 (15%) | 1 (6%) | |
Triglycerides (mmol/l) | 525 (100%) | 2.7 (2.4) | 3.0 (1.6) | 2.1 (2.2) | 2.2 (0.9) |
Statin treatment | 501 (95%) | 163 (98%) 4 (2%) | 13 (100%) 0 (0%) | 303 (99%) 3 (1%) | 15 (100%) 0 (0%) |
aPWV (m/s) | 480 (91%) | 8.6 (1.4) | 9.3 (1.8) | 8.8 (1.4) | 9.1 (1.6) |
rPWV | 496 (94%) | 9.1 (1.2) | 9.0 (1.5) | 8.9 (1.3) | 8.5 (1.3) |
MAP (mmHg) | 493 (94%) | 107.5 (13.2) | 103.9 (9.9) | 106.7 (14.6) | 106.4 (16.3) |
Aix@75 (%) | 499 (95%) | 18.1 (8.8) | 16.3 (9.1) | 30.3 (7.8) | 28.1 (14.1) |